Abstract | OBJECTIVE: METHODS: We searched eligible studies about ApaI polymorphism and osteoporosis through the PubMed, Embase, CNKI and Wanfang databases; case-control studies containing available genotype frequencies of A/a were chosen. We used the odds ratio with 95% confidence interval to assess the strength of this association. Sensitivity analysis and publication bias assessment were performed. Trial sequential analysis ( TSA) was performed to evaluate a sufficient sample. RESULTS: Twenty-two studies assessed the relationship between ApaI polymorphism and the risk of osteoporosis in postmenopausal women. The comprehensive analyses showed no significant association for ApaI polymorphism with postmenopausal osteoporosis in the overall population, equally valid for Asian and Caucasian subgroups with any genetic model. TSA still indicated the results were robust. CONCLUSION:
|
Authors | B Wang, H Li, C Yang, R Nie, X Zhang, C Pu |
Journal | Climacteric : the journal of the International Menopause Society
(Climacteric)
Vol. 26
Issue 6
Pg. 583-593
(Dec 2023)
ISSN: 1473-0804 [Electronic] England |
PMID | 37477999
(Publication Type: Meta-Analysis, Journal Article)
|
Chemical References |
- Receptors, Calcitriol
- VDR protein, human
|
Topics |
- Female
- Humans
- Osteoporosis, Postmenopausal
(genetics)
- Genetic Predisposition to Disease
- Receptors, Calcitriol
(genetics)
- Polymorphism, Genetic
- Osteoporosis
|